Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Metformin and physical performance in older people with probable sarcopenia and physical prefrailty or frailty in England (MET-PREVENT): a double-blind, randomised, placebo-controlled trial

The Lancet Healthy Longevity(2025)10.1016/j.lanhl.2025.100695Source: DataRank Database

Metformin and physical performance in older people with probable sarcopenia and physical prefrailty or frailty in England (MET-PREVENT): a double-blind, randomised, placebo-controlled trial is a research paper published in The Lancet Healthy Longevity (2025). On theSindex it has a DataRank of 0.553. It has been cited 39 times.

N/A

0.553DataRank · unranked

Scored on demand from live citation data

39 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 23.11)OA: goldTopics (47)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.553

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (19)

Claire McDonald ORCID,Nina Wilson ORCID,Katherine J Rennie,Michelle Bardgett,Penny Bradley ORCID

Live enrichment

PubMed:40147475 OpenAlex:https://openalex.org/W4408778766

NIHR Newcastle Biomedical Research Centre

Grant: IS_BRC_1215_20001

National Institute for Health and Care Research

Plymouth University

Leeds Biomedical Research Centre

University of Aberdeen

FWCI

23.11

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.lanhl.2025.100695

publisherhttps://doi.org/10.1016/j.lanhl.2025.100695

publisherhttps://api.elsevier.com/content/article/PII:S2666756825000145?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666756825000145?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40147475

Fields of Study

Nutrition and Health in AgingFrailty in Older AdultsMetabolism, Diabetes, and CancerHumansMetforminDouble-Blind MethodMaleFemaleAgedSarcopeniaAged, 80 and overPhysical Functional PerformanceFrailtyHand StrengthEnglandHypoglycemic AgentsWalking SpeedFrail Elderly

MeSH Terms

Walking SpeedFrailtyPhysical Functional PerformanceAgedAged, 80 and overDouble-Blind MethodEnglandFemaleHumansHypoglycemic AgentsMaleMetforminFrail ElderlyHand StrengthSarcopenia

Keywords

SarcopeniaMedicineGerontologyElderly peopleRandomized controlled trialPlaceboPhysical therapyOlder peopleMetforminPhysical medicine and rehabilitationInternal medicineDiabetes mellitusAlternative medicineEndocrinology

Metformin and physical performance in older people with probable sarcopenia and physical prefrailty or frailty in England (MET-PREVENT): a double-blind, randomised, placebo-controlled trial

FAIR Checklist

DataRank Breakdown

Authors (19)

Funding (5 grants)

Impact

Open Access

Topics